Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 21.95
-0.25 (-1.13%)
Sep 18, 2026, 5:36 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.61 billion as of September 18, 2026. Its market cap has increased by 12.50% in one year.
Market Cap
1.61B
Enterprise Value
2.12B
Revenue
1.03B
Ranking
n/a
PE Ratio
17.56
Stock Price
€21.95
ChartMarket Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.61B, an increase of 415.73%. That is a compound annual growth rate of 9.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.61B | 3.20% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 54.28B |
| UCB SA | 39.77B |
| Financière de Tubize | 7.91B |
| Ion Beam Applications | 443.89M |
| Onward Medical | 200.94M |
| Nyxoah | 134.90M |
| Hyloris Pharmaceuticals | 118.16M |
| Sequana Medical NV | 43.56M |